个人简介
邹文俊 博士、教授、博士研究生导师、药学院临床中药系。现任中华中医药学会中成药分会委员会常务委员、中华中医药学会临床中药学分会委员会常务委员、中国毒理学会临床毒理专业委员会委员，担任国家科技部国际合作项目、国家科技进步奖、国家自然基金、四川省科技厅、成都市科技项目评审专家、四川省知识产权局项目评审专家委员会委员。2011.12年入选国家知识产权局知识产权专家库专家，2012.12年入选国家知识产权局首批“知识产权领军人才”，2017年至今担任学校中医药知识产权运营中心主任。
主要从事中药疗效机理研究、临床合理用药评价研究、中药国际化及中药知识产权研究，近年来在中药欧盟注册研究、中药知识产权研究等方面成绩突出。先后获得国家自然科学基金面上项目“地榆有效成分促血小板生成作用及其调控TPO/c-Mpl表达和信号途径的研究”、国家科技部重大新药创制专项“地奥心血康胶囊欧盟注册研究”等国家级科研项目立项资助，累计参与承担国家级课题 7项，部（省）级课题12项，厅（局）级课题4项，其中课题负责人12项；公开发表学术论文88篇，其中第一或通讯作者（含共同通讯）51篇，SCI论文20篇，编写专著4部，申请授权发明专利26项。承担本科《临床中药学》、《中医药学概论》、研究生《临床中药学选论》、《药事管理选论》等课程教学，培养硕博士研究生30余名。代表性成果：（1）作为课题负责人或课题组长承担国家科技部“十五”、“十一五”、“十二五”期间有关 “中药欧盟注册研究”课题研究，围绕欧盟植物药监管体系、中药欧盟注册的关键环节与问题开展了深入系统研究，为我国中成药产品进入欧盟提供了重要理论指导，同时与成都地奥制药集团有限公司合作攻关，实现了中药产品“地奥心血康胶囊”以药品身份进入欧盟成员国市场零的突破。（2）以中药地榆“止血”的传统应用为出发点，首次发现报道了地榆皂苷和鞣质类成分具有升高白细胞、红细胞、血小板等促造血方面相关多种药理活性及其分子机制，为中药地榆的系统研究开发奠定重要基础。（3）先后主持完成“中药制药装备专利导航研究”、“高校职务发明专利转移转化模式与管理机制研究”、“中药姜黄产业链知识产权保护网络构建研究”等10余项国家和省级中医药知识产权相关课题研究，其中参与完成“四川省中药行业知识产权保护战略研究”课题，并获得国家知识产权局软科学优秀成果一等奖。
代表性成果
[1]Qu Liping; Tan Wanxian; Yang Jing; Lai Limin; Liu Sili; Wu Jianming^*; Zou Wenjun^*; Combination Compositions Composed of l-Glutamine and Si-Jun-Zi-Tang Might Be a Preferable Choice for 5-Fluorouracil-Induced Intestinal Mucositis: An Exploration in a Mouse Model, Frontiers in pharmacology, 2020, 11(918): 1-11.
[2]Bai Chongfei; Sun Yueshan; Pan Xianchao; Yang Jing; Li Xiaoxuan; Wu Anguo; Qin Dalian; Cao Shousong; Zou Wwnjun^*; Wu Jianming^*; Antitumor Effects of Trimethylellagic Acid Isolated From Sanguisorba officinalis L. On Colorectal Cancer via Angiogenesis Inhibition and Apoptosis Induction, Frontiers in pharmacology, 2020, 10(1646): 1-13.
[3]Wen Jianxia; Zhang Lu; Wang Jian; Wang Jiabo; Wang Lifu; Wang Ruilin; Li Ruisheng; Liu Honghong; Wei Shizhang; Li Haotian; Zou Wenjun^*; Zhao Yanling^*; Therapeutic Effects of Higenamine Combined With [6]-gingerol on Chronic Heart Failure Induced by Doxorubicin via Ameliorating Mitochondrial Function, Journal of cellular and molecular medicine, 2020, 00: 1-15.
[4]Gao Sijia; Zhou Xuelin; Lang Liwei; Liu Honghong; Li Jiayu; Li Haotian; Wei Shizhang; Wang Dan; Xu Zhou; Cai Huadan; Zhao Yanling^*; Zou Wenjun^*; Simultaneous Determination of Schisandrin and Promethazine With Its Metabolite in Rat Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study, International journal of analytical chemistry, 2019, 2019(**): 1-13.
[5]Li Chunlu; Li Xiaoxuan; Huang Feihong; Yang Jing; Wu Anguo; Wang Long; Qin Dalian; Zou Wenjun^*; Wu Jianming^*; Efficacy and Safety of Avatrombopag in Patients with Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Frontiers in pharmacology, 2019, 10(829): 1-12.
[6]Wang Yingying; Wei Shizhang; Gao Tian; Yang Yuxue; Lu Xiaohua; Zhou Xuelin; Li Haotian; Wang Tao; Qian Liqi; Zhao Yanling; Zou Wenjun^*; Anti-Inflammatory Effect of a TCM Formula Li-Ru-Kang in Rats With Hyperplasia of Mammary Gland and the Underlying Biological Mechanisms, Frontiers in pharmacology, 2018, 9(1318): 1-14.
[7]Qu Liping; Li Didi; Gao Xiaoping; Li Yongwei; Wu Jianming^*; Zou Wenjun^*; Di'ao Xinxuekang Capsule; a Chinese Medicinal Product; Decreases Serum Lipids Levels in High-Fat Diet-Fed ApoE(-/-) Mice by Downregulating PCSK9, Frontiers in pharmacology, 2018, 9(1170): 1-10.
[8]Qu Liping; Zou Wenjun^*; Wang Yitao; Wang Mei; European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States, Phytomedicine, 2018, 42: 219-225.
[9]Yu Ya; Li Xiang; Qu Liping; Chen Yang; Dai Yanping; Wang Mei; Zou Wenjun^*; DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators, Journal of ethnopharmacology, 2016, 3(178): 199-208.
[10]Liping Qu; Wenjun Zou^*; Zhenxiang Zhou; Tingmo Zhanga; JanVander Greefc; Mei Wang; Non-European traditional herbal medicines in Europe: a Community herbal monograph perspective, Journal of ethnopharmacology, 2014, 156: 107-114.
[11]Gao Xiaoping; Wu Jianming; Dai Yanping^*; Zou Wenjun^*; Two Ellagic Acids Isolated from Roots of Sanguisorba officinalis L. Promote Hematopoietic Progenitor Cell Proliferation and Megakaryocyte Differentiation, Molecules, 2014, 19(4): 5448-5458.
[12]瞿礼萍; 曾洁; 黄倩倩; 康琪; 王一涛^*; 邹文俊^*; 藏药Padma Circosan胶囊对复方中药产品欧盟简化注册的启示, 中草药, 2019, 50(18): 4511-4516.
[13]熊晏; 张晓群; 谭婉贤; 李力; 瞿礼萍^*; 邹文俊^*; 地奥心血康胶囊治疗心绞痛有效性与安全性的Meta分析, 中草药, 2018, 49(11): 2708-2714+2721.
[14]邹文俊; 刘芳; 吴建明; 高小平^*; 地榆总皂苷促造血细胞增殖效应研究, 中草药, 2012, 43(5): 929-933.
[15]邹文俊^*; 瞿礼萍; 叶祖光; 姬建新; 李伯刚; 欧盟传统草药专论述评, 中国中药杂志, 2011, 36(23): 3386-3388.